Literature DB >> 3920308

Maturational and functional diversity of human B lymphocytes delineated with anti-Leu-8.

G S Kansas, G S Wood, E G Engleman.   

Abstract

Human B lymphocyte subpopulations distinguished by their expression of the Leu-8 antigen were studied and found to differ in their respective maturational state and functional repertoire. The absence of Leu-8 expression correlated with an early step in antigen-driven B cell differentiation in that 1) as presented in the companion paper, germinal center B lymphocytes were uniformly Leu-8-, whereas mantle zone B cells were virtually all Leu-8+; 2) treatment of Leu-8+ B cells with the combination of rabbit anti-human mu-chain and B cell growth factor (BCGF), but not with either reagent alone, caused the loss of Leu-8 expression in addition to causing these cells to proliferate; and 3) only the Leu-8- B cell subset contained cells expressing the 4F2 activation antigen. Functional studies of peripheral blood B cells revealed that B cells giving rise to antibody-forming cells in the presence of T cells and pokeweed mitogen (PWM) were found almost exclusively in the Leu-8- subset of B cells, even though this subset comprised a minority of circulating B lymphocytes. By contrast, Leu-8+ B cells proliferated more vigorously than Leu-8- B cells to formalinized Staphylococcus aureus Cowan I (SAC). These data demonstrate that Leu-8 is an important maturational and functional marker for human B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920308

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Multiple roles of Leu-8/MEL-14 in leukocyte adhesion and function.

Authors:  S P James; Y Murakawa; M E Kanof; M Berg
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 2.  Cross-linking the Leu-8 lymph node homing receptor on B cells inhibits immunoglobulin synthesis.

Authors:  Y Murakawa; W Strober; S P James
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Phenotype of chronic lymphocytic leukemia (CLL) B-cells. B-CLL cells express the Leu-8 antigen.

Authors:  A Cafaro; M Napolitano; V Zoli; L Pacilli; I Mezzaroma; A De Laurenzi; F Pandolfi
Journal:  Blut       Date:  1987-01

4.  A comparison between monoclonal antibody MT2 and immunoglobulin staining in the differential diagnosis of follicular lymphoid proliferations in routinely fixed wax-embedded biopsies.

Authors:  A J Norton; C Rivas; P G Isaacson
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

Review 5.  Surface antigens associated with human B cell activation.

Authors:  L K Jung
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 6.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

7.  Adhesion receptor profile of thymic B-cell lymphoma.

Authors:  A Eichelmann; K Koretz; G Mechtersheimer; P Möller
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

8.  Venular endothelium binding molecules CD44 and LECAM-1 in normal and malignant B-cell populations. A comparative study.

Authors:  P Möller; A Eichelmann; F Leithäuser; G Mechtersheimer; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.

Authors:  J V Giorgi; P G Nishanian; I Schmid; L E Hultin; H L Cheng; R Detels
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

10.  CD4 lymphocyte subset abnormalities associated with impaired delayed cutaneous hypersensitivity reactions in patients with X-linked agammaglobulinaemia.

Authors:  A D Crockard; N A Boyd; T A McNeill; D R McCluskey
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.